相关实验视频

Updated: Sep 17, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

代谢综合征成分的动态变化与扩散大B细胞淋巴瘤的临床结果的关联

Dewan Zhao¹, He Xu¹, Fengrao Tang²

¹Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

Frontiers in oncology

|July 1, 2025

概括

控制低密度脂蛋白胆固醇 (LDL-C) 和保持适度的体重指数 (BMI) 可以改善扩散性大B细胞淋巴瘤 (DLBCL) 患者的结果. 这些代谢因素在DLBCL治疗中显著影响完全缓解,无进展生存率和整体生存率.

科学领域:

在瘤学瘤学.
代谢医学是一种代谢医学.
临床研究临床研究

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的非霍奇金淋巴瘤 (NHL),尽管目前的治疗方法,但很大一部分患者面临着不良预后.
代谢综合征 (MetS) 对DLBCL结果的影响还不清楚,需要进一步调查其组件的影响.

研究的目的:

研究代谢综合征 (MetS) 组件的动态变化对分散型大B细胞淋巴瘤 (DLBCL) 患者治疗结果和预后的影响.
确定与DLBCL完全缓解 (CR),无进展生存 (PFS) 和总生存 (OS) 相关的特定MetS轨迹.

主要方法:

对125名新诊断的DLBCL患者进行了回顾性分析,这些患者接受了CHOP或CHOP类疗法治疗.
利用基于组的轨迹模型来识别MetS组件轨迹.
使用多变量逻辑回归和Cox比例危险回归来评估影响CR,PFS和OS的因素.

主要成果:

基线高高密度脂蛋白胆固醇 (HDL-C) 与进展风险降低有关 (HR = 0.27).
高基线低密度脂蛋白胆固醇 (LDL-C) 与降低CR率 (OR = 0.65) 和增加进展风险 (HR = 1.78) 相关.
适度的体重指数 (BMI) 轨迹与改善的CR,PFS和OS相关,而高的LDL-C轨迹与减少的CR相关.

结论:

控制LDL-C水平对于提高完全缓解率和降低DLBCL进展风险至关重要.
维持适度的BMI与DLBCL患者的改善临床结果有关,包括CR,PFS和OS.
对LDL-C和BMI等MetS组件的动态监测和管理代表了提高DLBCL治疗疗效的潜在策略.

关键词:

在HDL胆固醇.这就是为什么LDL胆固醇是LDL胆固醇.身体质量指数 (BMI) 是指身体质量指数.扩散大的B细胞淋巴瘤.代谢综合征代谢综合征

更多相关视频

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

相关概念视频

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...